These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1065887)

  • 1. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2365-9. PubMed ID: 1065887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplication-stimulating activity (MSA): a somatomedin-like polypeptide from cultured rat liver cells.
    Nissley SP; Rechler MM
    Natl Cancer Inst Monogr; 1978 May; (48):167-77. PubMed ID: 748750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of three molecular forms of insulin-like growth factor II from human Cohn paste IV.
    Straczek J; Heulin MH; Chenut AM; Lasbennes A; Geschier C; Belleville F; Nabet P
    J Chromatogr; 1990 Nov; 532(2):237-48. PubMed ID: 2084122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of ornithine decarboxylase activity in chick fibroblasts by non-suppressible insulin-like activity (NSILA), insulin and serum.
    Haselbacher GK; Humbel RE
    J Cell Physiol; 1976 Jun; 88(2):239-45. PubMed ID: 5458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor.
    Megyesi K; Kahn CR; Roth J; Neville DM; Nissley SP; Humbel RE; Froesch ER
    J Biol Chem; 1975 Dec; 250(23):8990-6. PubMed ID: 391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.
    Kahn CR; Megyesi K; Roth J
    J Clin Invest; 1976 Feb; 57(2):526-9. PubMed ID: 1254732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a receptor for somatomedin-like polypeptides in human fibroblasts.
    Rechler MM; Nissley SP; Podskalny JM; Moses AC; Fryklund L
    J Clin Endocrinol Metab; 1977 May; 44(5):820-31. PubMed ID: 192752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification of low molecular weight non-suppressible insulin-like activity from human plasma: demonstration of the presence of multiple forms.
    Cockerill PN; Cornell HJ; Herington AC
    J Endocrinol; 1980 May; 85(2):266-77. PubMed ID: 7400715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs.
    Schlumpf U; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.